Lawsuit for Investors in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares announced by Shareholders Foundation
November 29 2016 - 9:45AM
The Shareholders Foundation, Inc. announces that a lawsuit was
filed in New York on behalf of certain purchasers of shares of
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) over alleged Securities
Laws Violations by Alexion Pharmaceuticals, Inc.
Investors who purchased shares of Alexion Pharmaceuticals, Inc.
(NASDAQ:ALXN) have certain options and for certain investors there
are short and strict deadlines running. Deadline: January 17, 2017.
NASDAQ: ALXN investors should contact the Shareholders Foundation
at mail@shareholdersfoundation.com or call +1(858) 779 -
1554.
The plaintiff alleges that the defendants issued materially
false and misleading statements to investors and/or failed to
disclose that Alexion Pharmaceuticals, Inc employed improper sales
practices with respect to Soliris, that consequently, Alexion’s
revenues from Soliris sales were unlikely to be sustainable, and
that as a result, Alexion’s public statements were materially false
and misleading at all relevant times.
On November 9, 2016, Alexion Pharmaceuticals, Inc announced that
the Audit and Finance Committee of the Board of Directors is
conducting an investigation into allegations that recently have
been made by a former employee with respect to the Company’s sales
practices of Soliris. Alexion Pharmaceuticals, Inc said that the
Audit and Finance Committee is investigating whether Company
personnel have engaged in sales practices that were inconsistent
with Company policies and procedures and the related disclosure and
other considerations raised by such practices and that the Audit
and Finance Committee has retained outside counsel to assist it in
the investigation.
Those who purchased Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio
legal monitoring and a settlement claim filing service, which does
research related to shareholder issues and informs investors of
securities class actions, settlements, judgments, and other legal
related news to the stock/financial market. The Shareholders
Foundation, Inc. is not a law firm. The information is provided as
a public service. It is not intended as legal advice and should not
be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Apr 2023 to Apr 2024